MedPath

A study to evaluate the efficacy of pectoral nerve block ie to make pectoral nerve numb, as a pain killer in breast cancer patients after their surgery.

Not Applicable
Conditions
Health Condition 1: null- ASA I/ ASA II patients posted for unilateral non-reconstructive mastectomy
Registration Number
CTRI/2017/04/008289
Lead Sponsor
Tata Memorial Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

1.ASA I/ ASA II patients

2.Posted for unilateral non-reconstructivemastectomy.

3.Informed consent

Exclusion Criteria

1.Sensitivity to local anaesthetic agent.

2.Bleeding disorders or receiving anticoagulants.

3.Body mass index (BMI) > 35/kg/m2.

4.Pregnancy.

5.Post radiation patients.

6.Patients on other studies which can interfere with the outcome of the study.

7.Patients with deranged liver function test and renal function test.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Immediate post operative pain scores at rest and movement after shifting the patient to recovery and then 2 hourly till 6 hours <br/ ><br>2.Time to rescue analgesia.Timepoint: Post operative pain scores at rest and movement after shifting the patient to recovery and then at 2hrs, 4 hrs and 6 hrs.
Secondary Outcome Measures
NameTimeMethod
1.Total intraoperative fentanyl consumption <br/ ><br>2.Postoperative pain scores at 12, 18 and 24 hours or at discharge whichever is earlier. <br/ ><br>3.Post operative nausea vomiting. <br/ ><br>4.Patient satisfaction. <br/ ><br>5.Complications, if any. <br/ ><br>Timepoint: Postoperative 12, 18 and 24 hours
© Copyright 2025. All Rights Reserved by MedPath